{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:14:24Z","timestamp":1773281664335,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T00:00:00Z","timestamp":1463356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/pr.2016.105","type":"journal-article","created":{"date-parts":[[2016,7,20]],"date-time":"2016-07-20T13:24:17Z","timestamp":1469021057000},"page":"554-565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pharmacologic synergism of ocular ketorolac and systemic caffeine citrate in rat oxygen-induced retinopathy"],"prefix":"10.1038","volume":"80","author":[{"given":"Jacob V.","family":"Aranda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taimur","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim","family":"Bronshtein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Sadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria B.","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas R.","family":"Lazzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay D.","family":"Beharry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,16]]},"reference":[{"key":"BFpr2016105_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","volume":"382","author":"A Hellstr\u00f6m","year":"2013","unstructured":"Hellstr\u00f6m A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet 2013;382:1445\u201357.","journal-title":"Lancet"},{"key":"BFpr2016105_CR2","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1016\/j.ghir.2004.03.030","volume":"14 Suppl A","author":"LE Smith","year":"2004","unstructured":"Smith LE. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res 2004;14 Suppl A:S140\u20134.","journal-title":"Growth Horm IGF Res"},{"key":"BFpr2016105_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1542\/peds.111.2.339","volume":"111","author":"LC Chow","year":"2003","unstructured":"Chow LC, Wright KW, Sola A ; CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003;111:339\u201345.","journal-title":"Pediatrics"},{"key":"BFpr2016105_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000329922","volume":"100","author":"RJ Martin","year":"2011","unstructured":"Martin RJ, Wang K, K\u00f6ro\u011flu O, Di Fiore J, Kc P. Intermittent hypoxic episodes in preterm infants: do they matter? Neonatology 2011;100:303\u201310.","journal-title":"Neonatology"},{"key":"BFpr2016105_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/pr.2012.132","volume":"72","author":"JM Di Fiore","year":"2012","unstructured":"Di Fiore JM, Kaffashi F, Loparo K, et al. The relationship between patterns of intermittent hypoxia and retinopathy of prematurity in preterm infants. Pediatr Res 2012;72:606\u201312.","journal-title":"Pediatr Res"},{"key":"BFpr2016105_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/sj.jp.7211040","volume":"24","author":"JR York","year":"2004","unstructured":"York JR, Landers S, Kirby RS, Arbogast PG, Penn JS. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol 2004;24:82\u20137.","journal-title":"J Perinatol"},{"key":"BFpr2016105_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jpeds.2010.01.046","volume":"157","author":"JM Di Fiore","year":"2010","unstructured":"Di Fiore JM, Bloom JN, Orge F, et al. A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr 2010;157:69\u201373.","journal-title":"J Pediatr"},{"key":"BFpr2016105_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1007374","volume":"364","author":"HA Mintz-Hittner","year":"2011","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011;364:603\u201315.","journal-title":"N Engl J Med"},{"key":"BFpr2016105_CR9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.earlhumdev.2012.09.019","volume":"88","author":"HA Mintz-Hittner","year":"2012","unstructured":"Mintz-Hittner HA. Treatment of retinopathy of prematurity with vascular endothelial growth factor inhibitors. Early Hum Dev 2012;88:937\u201341.","journal-title":"Early Hum Dev"},{"key":"BFpr2016105_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ophtha.2011.04.028","volume":"118","author":"DM Moshfeghi","year":"2011","unstructured":"Moshfeghi DM, Berrocal AM. Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice. Ophthalmology 2011;118:1227\u20138.","journal-title":"Ophthalmology"},{"key":"BFpr2016105_CR11","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1651-2227.2011.02445.x","volume":"100","author":"AL H\u00e5rd","year":"2011","unstructured":"H\u00e5rd AL, Hellstr\u00f6m A. On safety, pharmacokinetics and dosage of bevacizumab in ROP treatment - a review. Acta Paediatr 2011;100:1523\u20137.","journal-title":"Acta Paediatr"},{"key":"BFpr2016105_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3109\/14767058.2010.517704","volume":"23 Suppl 3","author":"JV Aranda","year":"2010","unstructured":"Aranda JV, Beharry K, Valencia GB, Natarajan G, Davis J. Caffeine impact on neonatal morbidities. J Matern Fetal Neonatal Med 2010;23 Suppl 3:20\u20133.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"BFpr2016105_CR13","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Davis P, et al.; Caffeine for Apnea of Prematurity Trial Group. Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354:2112\u201321.","journal-title":"N Engl J Med"},{"key":"BFpr2016105_CR14","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa073679","volume":"357","author":"B Schmidt","year":"2007","unstructured":"Schmidt B, Roberts RS, Davis P, et al.; Caffeine for Apnea of Prematurity Trial Group. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357:1893\u2013902.","journal-title":"N Engl J Med"},{"key":"BFpr2016105_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1385\/JMN:24:2:201","volume":"24","author":"N Sahir","year":"2004","unstructured":"Sahir N, Evrard P, Gressens P. Caffeine induces sonic hedgehog gene expression in cultured astrocytes and neurons. J Mol Neurosci 2004;24:201\u20135.","journal-title":"J Mol Neurosci"},{"key":"BFpr2016105_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1124\/mol.106.032920","volume":"72","author":"S Merighi","year":"2007","unstructured":"Merighi S, Benini A, Mirandola P, et al. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 2007;72:395\u2013406.","journal-title":"Mol Pharmacol"},{"key":"BFpr2016105_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/jcp.22180","volume":"224","author":"WH Liu","year":"2010","unstructured":"Liu WH, Chang LS. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+\/ROS-mediated suppression of ERK\/c-fos pathway and activation of p38 MAPK\/c-jun pathway. J Cell Physiol 2010;224:775\u201385.","journal-title":"J Cell Physiol"},{"key":"BFpr2016105_CR18","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1167\/iovs.06-0057","volume":"47","author":"KD Beharry","year":"2006","unstructured":"Beharry KD, Modanlou HD, Hasan J, et al. Comparative effects of early postnatal ibuprofen and indomethacin on VEGF, IGF-I, and GH during rat ocular development. Invest Ophthalmol Vis Sci 2006;47:3036\u201343.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016105_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0008-6363(00)00084-5","volume":"47","author":"P Hardy","year":"2000","unstructured":"Hardy P, Dumont I, Bhattacharya M, et al. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc Res 2000;47:489\u2013509.","journal-title":"Cardiovasc Res"},{"key":"BFpr2016105_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1076\/ceyr.27.5.309.17222","volume":"27","author":"J Sharma","year":"2003","unstructured":"Sharma J, Barr SM, Geng Y, Yun Y, Higgins RD. Ibuprofen improves oxygen-induced retinopathy in a mouse model. Curr Eye Res 2003;27:309\u201314.","journal-title":"Curr Eye Res"},{"key":"BFpr2016105_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0090-6980(83)90041-2","volume":"25","author":"TF Yeh","year":"1983","unstructured":"Yeh TF, Raval D, Pyati S, Pildes RS. Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA). Prostaglandins 1983;25:385\u201391.","journal-title":"Prostaglandins"},{"key":"BFpr2016105_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3928\/15428877-20091230-08","volume":"41","author":"RD Goldman","year":"2010","unstructured":"Goldman RD, Spierer A, Zhurkovsky A, Kwint J, Schwarcz M, Ben Simon GJ. Retinopathy of prematurity in very low birth weight infants and the potential protective role of indomethacin. Ophthalmic Surg Lasers Imaging 2010;41:41\u20137.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"BFpr2016105_CR23","first-page":"4","volume":"7","author":"M Avila-Vazquez","year":"2004","unstructured":"Avila-Vazquez M, Maffrand R, Sosa M, et al. Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study, BMC Pediatr 2004; 7:4\u201315.","journal-title":"BMC Pediatr"},{"key":"BFpr2016105_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00128072-200103040-00003","volume":"3","author":"JD Reynolds","year":"2001","unstructured":"Reynolds JD. The management of retinopathy of prematurity. Paediatr Drugs 2001;3:263\u201372.","journal-title":"Paediatr Drugs"},{"key":"BFpr2016105_CR25","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1167\/iovs.14-15321","volume":"56","author":"S Jivabhai Patel","year":"2015","unstructured":"Jivabhai Patel S, Bany-Mohammed F, McNally L, et al. Exogenous Superoxide Dismutase Mimetic Without Scavenging H2O2 Causes Photoreceptor Damage in a Rat Model for Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci 2015;56:1665\u201377.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016105_CR26","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1021\/pr501238m","volume":"14","author":"C Tu","year":"2015","unstructured":"Tu C, Beharry KD, Shen X, et al. Proteomic profiling of the retinas in a neonatal rat model of oxygen-induced retinopathy with a reproducible ion-current-based MS1 approach. J Proteome Res 2015;14:2109\u201320.","journal-title":"J Proteome Res"},{"key":"BFpr2016105_CR27","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.1167\/iovs.13-13040","volume":"54","author":"KD Beharry","year":"2013","unstructured":"Beharry KD, Cai CL, Sharma P, et al. Hydrogen peroxide accumulation in the choroid during intermittent hypoxia increases risk of severe oxygen-induced retinopathy in neonatal rats. Invest Ophthalmol Vis Sci 2013;54:7644\u201357.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFpr2016105_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1203\/PDR.0b013e318204e6fa","volume":"69","author":"RS Brock","year":"2011","unstructured":"Brock RS, Gebrekristos BH, Kuniyoshi KM, Modanlou HD, Falcao MC, Beharry KD. Biomolecular effects of JB1 (an IGF-I peptide analog) in a rat model of oxygen-induced retinopathy. Pediatr Res 2011;69:135\u201341.","journal-title":"Pediatr Res"},{"key":"BFpr2016105_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1203\/PDR.0b013e31817307ac","volume":"64","author":"RJ Coleman","year":"2008","unstructured":"Coleman RJ, Beharry KD, Brock RS, Abad-Santos P, Abad-Santos M, Modanlou HD. Effects of brief, clustered versus dispersed hypoxic episodes on systemic and ocular growth factors in a rat model of oxygen-induced retinopathy. Pediatr Res 2008;64:50\u20135.","journal-title":"Pediatr Res"},{"key":"BFpr2016105_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1203\/00006450-199908000-00010","volume":"46","author":"BN Nandgaonkar","year":"1999","unstructured":"Nandgaonkar BN, Rotschild T, Yu K, Higgins RD. Indomethacin improves oxygen-induced retinopathy in the mouse. Pediatr Res 1999;46:184\u20138.","journal-title":"Pediatr Res"},{"key":"BFpr2016105_CR31","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/S0028-3908(00)00045-9","volume":"39","author":"BL Fiebich","year":"2000","unstructured":"Fiebich BL, Lieb K, H\u00fcll M, et al. Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E(2) synthesis in rat microglial cells. Neuropharmacology 2000;39:2205\u201313.","journal-title":"Neuropharmacology"},{"key":"BFpr2016105_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2007.02.016","volume":"37","author":"JM Dooley","year":"2007","unstructured":"Dooley JM, Gordon KE, Wood EP, Brna PM, MacSween J, Fraser A. Caffeine as an adjuvant to ibuprofen in treating childhood headaches. Pediatr Neurol 2007;37:42\u20136.","journal-title":"Pediatr Neurol"},{"key":"BFpr2016105_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejphar.2006.06.041","volume":"544","author":"JR L\u00f3pez","year":"2006","unstructured":"L\u00f3pez JR, Dom\u00ednguez-Ram\u00edrez AM, Cook HJ, et al. Enhancement of antinociception by co-administration of ibuprofen and caffeine in arthritic rats. Eur J Pharmacol 2006;544:31\u20138.","journal-title":"Eur J Pharmacol"},{"key":"BFpr2016105_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0165-3806(97)00004-7","volume":"99","author":"KE Binns","year":"1997","unstructured":"Binns KE, Salt TE. Post eye-opening maturation of visual receptive field diameters in the superior colliculus of normal- and dark-reared rats. Brain Res Dev Brain Res 1997;99:263\u20136.","journal-title":"Brain Res Dev Brain Res"},{"key":"BFpr2016105_CR35","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1159\/000115306","volume":"36","author":"SR Robinson","year":"1990","unstructured":"Robinson SR, Dreher B. The visual pathways of eutherian mammals and marsupials develop according to a common timetable. Brain Behav Evol 1990;36:177\u201395.","journal-title":"Brain Behav Evol"},{"key":"BFpr2016105_CR36","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1542\/peds.112.5.1016","volume":"112","author":"A Hellstr\u00f6m","year":"2003","unstructured":"Hellstr\u00f6m A, Engstr\u00f6m E, H\u00e5rd AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics 2003;112:1016\u201320.","journal-title":"Pediatrics"},{"key":"BFpr2016105_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1124\/mol.106.032920","volume":"72","author":"S Merighi","year":"2007","unstructured":"Merighi S, Benini A, Mirandola P, et al. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol  2007;72:395\u2013406.","journal-title":"Mol Pharmacol"},{"key":"BFpr2016105_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1194\/jlr.R000232","volume":"51","author":"RVS Rajala","year":"2010","unstructured":"Rajala RVS. Phosphoinositide 3-kinase signaling in the vertebrate retina. J Lipid Res 2010;51:4\u201322.","journal-title":"J Lipid Res"},{"key":"BFpr2016105_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature10908","volume":"484","author":"R Benedito","year":"2012","unstructured":"Benedito R, Rocha SF, Woeste M, et al. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 2012;484:110\u20134.","journal-title":"Nature"},{"key":"BFpr2016105_CR40","doi-asserted-by":"publisher","first-page":"11709","DOI":"10.1073\/pnas.95.20.11709","volume":"95","author":"B Olofsson","year":"1998","unstructured":"Olofsson B, Korpelainen E, Pepper MS, et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci USA 1998;95:11709\u201314.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr2016105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016105","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr2016105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:00:09Z","timestamp":1684616409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr2016105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,16]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFpr2016105"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.105","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,16]]},"assertion":[{"value":"29 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}